Diasorin LIAISON Mumps IgG - HSA Registration DE0507604
Access comprehensive regulatory information for Diasorin LIAISON Mumps IgG in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507604 and owned by DiaSorin Italia S.p.A.. The device was registered on December 14, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The LIAISON® Mumps IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi- quantitative determination of specific IgG antibodies to mumps virus in human serum samples. It is intended to be used as an aid in the determination of serological status to mumps virus. The test has to be performed on the LIAISON® Analyzer family.